| |
|
|
|
Xtalks, Online
2024-06-17
Discover an informative webinar that focuses on the diverse architectures of bi-specific antibody (bsAb) therapeutics and highlights the innovative strategies employed for their production.
Bi-specific antibodies (bsAbs) demonstrate novel functionalities that yield remarkable promise in improving the drug therapeutic efficacy through the recognition and targeting of two different antigens or epitopes. Although the optimized purification of mAbs serves as a good starting point for the purification of bsAbs, further optimization is challenging due to the differences in their intrinsic structure.
In this webinar, the expert speaker will provide insights into the various architectures of BsAbs, focusing on strategies for production.
Register for this webinar today to gain insights into the unique challenges and innovative solutions in bispecific antibody therapeutics, their ability to target dual antigens and the diverse architectures that enhance therapeutic efficacy.
Keywords: Antibodies, Drug Development, Antibody, Drug Discovery, Cell Therapy, Biotherapeutics, Monoclonal Antibodies, Monoclonal Antibody, Basic Research, Bispecific Antibody
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Rob Ford, Field Application Scientist, GenScript Biotech
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-06-17
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|